Company intelligence / Profile preview
Solasia Pharma
Minato-ku, Tokyo, Japansolasia.co.jp ↗
- Ownership
- Public · 4597
- Employees
- ~52
- Development stage
- Other
01
Overview
Solasia has successfully commercialized three products targeting oncology supportive care and rare cancers across Asia. Sancuso®, DARVIAS®, and episil® are all marketed. The company continues to develop new indications and expand into additional geographies while advancing preclinical assets focused on chemotherapy side effects and solid tumors. Early-stage collaborations aim to add gene therapy capabilities.
- Therapeutic areas
- OncologyNeurology
- Modalities
- Small moleculesmedical devicesgene therapy (in early research/collaboration)organic arsenic compounds
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
EditForce Inc. — R&D collaboration on RNA-editing/gene therapy technologiesIn-license agreements from global pharma/biotech companies—details not specified but core to business model
04
Financials
- Market cap
- $39.7M
- Total revenue
- $2.7M
- Enterprise value
- $32M
Beyond the preview
Go deeper on Solasia Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Solasia Pharma.